Stock Price Quote

INDO US BIO-TECH LTD.

NSE : INDOUSBSE : 541304ISIN CODE : INE250Z01010Industry : AgricultureHouse : Private
BSE99.00-0.3 (-0.3 %)
PREV CLOSE ( ) 99.30
OPEN PRICE ( ) 97.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 351
TODAY'S LOW / HIGH ( )96.90 100.20
52 WK LOW / HIGH ( )97.65 205.1
NSE99.67-0.18 (-0.18 %)
PREV CLOSE( ) 99.85
OPEN PRICE ( ) 98.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 24778
TODAY'S LOW / HIGH( ) 96.60 100.00
52 WK LOW / HIGH ( )97.32 206
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 04-02 2004
Management Info
- Chairman Jagdish Ajudia - Managing Director
Registered Office

Address 309, Shanti Mall, Satadhar Cross Road,Opp. Navrang Tower,Sola Road ,
Ahmedabad,
Gujarat-380061

Phone 079 2749 1807 / 9909043999

Email indous_jagdish@yahoo.co.in

Website www.indousagriseeds.com

Registrars Details
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE, NSE

NEWS

10Mar Clarification sought from Indo Us Bio
The Exchange has sought clarification from Indo Us Bio-Tech Ltd on March..
05Mar Indo US Bio Tech informs about disclos
Indo US Bio Tech has informed that the exchange has received the disclos..
18Feb Indo Us Bio-Tech informs about disclo
Indo Us Bio-Tech has informed that the exchange has received the disclos..
14Oct Indo Us Bio-Tech informs about outcome
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Ob..
29Aug Indo Us Bio Tech informs about newsp
Indo Us Bio Tech has informed that it enclosed a copy of each newspaper..

Financials

in Millions
QTR Dec 25 ANNUAL 25
Net Profit29.97162.68
Gross Profit 31.64 165.31
Operating Profit 41.56191.17
Net Sales 227.981038.38

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Regaal Resources (BSE)
peergroup  87.68 (19.99%)
M.Cap ( in Cr)900.68
JK Agri Genetics (BSE)
peergroup  338.00 (3.46%)
M.Cap ( in Cr)156.73
Naturite Agro Prod. (BSE)
peergroup  207.30 (4.35%)
M.Cap ( in Cr)109.79
Rukmani Devi Garg (BSE)
peergroup  112.55 (4.21%)
M.Cap ( in Cr)99.90
TGIF Agribusiness (BSE)
peergroup  93.00 (3.91%)
M.Cap ( in Cr)24.06

Shareholding Pattern

PROMOTERS 70.17%
NON-INSTITUTION 29.83%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Indo US Bio-Tech Ltd.

Indo US Bio-Tech Ltd. was incorporated in the year 2004. Its today's share price is 99. Its current market capitalisation stands at Rs 198.51 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1038.38 Cr and Total Income of Rs.1040.2 Cr. The company's management includes Ritaben Nileshbhai Kikani, Shilpa Thumar, Neha Patel, Priyanka Ajudia, Maltiben Ajudia, Jagdish Ajudia, Dimpy Joshi.

It is listed on the BSE with a BSE Code of 541304 , NSE with an NSE Symbol of INDOUS and ISIN of INE250Z01010. It's Registered office is at 309, Shanti Mall, Satadhar Cross Road,Opp. Navrang Tower,Sola Road Ahmedabad-380061, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Bhagat & Associates, Gautam N Associates, Piyush J Shah & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.